title: [Stevens-Johnson's syndrome after treatment for ocular toxoplasmosis].
abstract: METHODS
  We present a case of a 9 year-old male, who was treated with sulfadiacine, pirimetamine and folinic acid following diagnosis of an active toxoplasmic chorioretinitis. After 9 days of treatment he developed serious multiorganic mucocutaneous lesions and was diagnosed with Stevens-Johnson's syndrome.
  
  
  CONCLUSIONS
  Stevens-Johnson's syndrome is a potentially fatal multiorganic disease, where drugs are clearly linked as causal factors. Fifty per cent of cases progress to severe ocular disease. The multiorganic aspect of the disease and its severity demand an early diagnosis and a multidisciplinary treatment.
authors.affiliation: Hospital Universitario 12 de Octubre, Madrid, Spain.
authors.forename: A I
authors.initials: AI
authors.lastname: Ramos Castrillo
authors.forename: P
authors.initials: P
authors.lastname: Tejada de Palacios
mesh_terms: D000890:Anti-Infective Agents / Q000009:adverse effects*; D002648:Child; D006801:Humans; D008297:Male; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D013449:Sulfonamides / Q000009:adverse effects*; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy*
chemical_list: D000890:Anti-Infective Agents; D013449:Sulfonamides